Kamada Announces Appointment of Amir London as Senior Vice President, Business Development

Search by Company

Alpha TAU Medical Ltd.

Ayala Pharmaceuticals Inc.

Brainsway Ltd.

Chemomab Therapeutics Ltd.

Elbit Vision Systems Ltd.

eToro Group Ltd.

Foamix Pharmaceuticals Ltd.

Galooli Ltd.

Gamida Cell Ltd.

Intec Pharma Ltd.

Kahr Medical Ltd.

Kamada Ltd.

Lightricks Ltd.

Mapi Pharma Ltd.

MeMed Diagnostics Ltd.

Minute Media Inc.

Polus Tech

PolyPid Ltd.

ReWalk Robotics Ltd.

SuperDerivatives Inc.

Syqe Medical Ltd.

Tipa Corp. Ltd.

Tomorrow.io

Trax Ltd.

Yotpo Ltd.

Kamada Announces Appointment of Amir London as Senior Vice President, Business Development

December 9, 2013 |

Kamada Ltd. (Nasdaq:KMDA)(TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the appointment of Amir London to the newly-created position of Senior Vice President, Business Development.